If you're looking to get your six-month-old vaccinated against COVID next year, you may end up giving him up to three jabs before the job is done:
Pfizer and BioNTech are testing a third dose of their Covid-19 vaccine in an ongoing trial of children ages 6 months to under 5 years after the companies found that the two-dose regimen didn't generate a strong enough immune response in some children, the companies announced Friday.
The change to the trial protocol means that the companies won't have data to submit to regulators until the first half of 2022. That's a change from earlier this month, when Pfizer CEO Albert Bourla said the company could have data on young kids by the end of this year.
In a news release posted Friday, the companies said two doses of the vaccine generated a strong immune response in kids under age 2, comparable to what was seen in a trial of 16- to 25-year-olds, but not in the cohort of children ages 2 to under 5.
Doing some simple math here and honestly I feel confident in saying that three shots feels like, you know, a lot of shots for a tiny little kid. 6 months old, really??
And presumably that doesn't even factor in boosters.
